Tuesday, February 8, 2022
New Haven, CT (Feb 8, 2022) – Yale New Haven Health (YNHHS) has appointed Scott A. Lupkas as vice president, Investments. Lupkas will oversee investment strategy for the YNHH’s nearly $6 billion in investment assets including operating assets, defined pension funds, and endowment as well as special investment programs. He will lead and further develop an in-house investment team focused on asset allocation, manager selection, and risk management efforts that supports the treasurer, the chief financial officer, and the System Investment Committee in the stewardship of assets. Lupkas will report to Michael Angelini, senior vice president, treasurer.
"Scott's diverse investment experience and leadership will enhance our ability to strategically manage Yale New Haven Health’s assets towards achieving mission critical financial objectives," said Angelini.
Lupkas was most recently vice president, Pension Investments for Raytheon Company where he was the chief investment officer overseeing pension and retirement funds including the company's investment strategies and assets for U.S. employee benefit plans. He has more than 20 years of extensive experience advancing investment organizations and managing both traditional and alternative asset class strategies. His previous roles include senior leadership posts at the UAW Retiree Medical Benefits Trust, Verdis Investment Management and the Brown University Investment Office.
“Being a part of Yale New Haven Health, an organization that is committed to innovation and quality in healthcare, research and service to the community, is an honor and I am excited to help ensure its financial strength. It is especially meaningful to me as a native of New Haven County and I am extraordinarily fortunate to be able to give back to an organization that has benefited so many, including my own family,” said Lupkas.
Lupkas holds an MBA from Yale School of Management and a bachelor's degree in economics and international business from New York University. He is a CFA® charterholder.
Yale New Haven Health (YNHHS), one of the largest and most comprehensive healthcare systems in Connecticut, is recognized for advanced clinical care, quality, service, cost effectiveness and commitment to improving the health status of the communities it serves. YNHHS includes five hospitals – Bridgeport, Greenwich, Lawrence + Memorial, Westerly and Yale New Haven hospitals, several specialty networks and Northeast Medical Group, a non-profit medical foundation with several hundred community-based and hospital-employed physicians. YNHHS is affiliated with Yale University and Yale Medicine, the clinical practice of the Yale School of Medicine and the largest academic multi-specialty practice in New England. Yale New Haven Hospital is the primary teaching hospital of Yale School of Medicine. www.ynhhs.org
9/9/2026
Yale New Haven Health Names Daniel del Portal, MD, MBA, Chief Clinical OfficerNEW HAVEN, Conn. (September 9, 2026) – Yale New Haven Health (YNHHS) today announced that Daniel del Portal, MD, MBA, has been named Executive Vice President and Chief Clinical Officer. In this role, Dr. del Portal will lead systemwide efforts to advance quality, safety, patient experience, clinical growth and operational performance across Yale New Haven Health.
9/1/2026
Hartford HealthCare and Yale New Haven Health Celebrate Grand Opening of Connecticut Proton CenterWALLINGFORD, CT (September 1, 2026) – Hartford HealthCare and Yale New Haven Health today celebrated the grand opening of the Connecticut Proton Center, marking a new era in cancer care and bringing the state's first proton beam therapy center to patients.
8/25/2026
Bridgeport Hospital Introduces Aquablation Therapy for Men with Enlarged ProstateBRIDGEPORT, CT (August 25, 2026) – Bridgeport Hospital is now offering Aquablation® therapy, an innovative, minimally invasive robotic-assisted procedure for men suffering from benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate. The first procedures were performed at Bridgeport Hospital following the program's launch in July 2026.